Search - tctmd.com

Displaying 61 - 80 of 1459

Sort: Relevancy | Date

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

Infections No More Likely With Reconditioned Versus New Pacemakers

Yael L. Maxwell

November 22, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

Advertisement

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Infections No More Likely With Reconditioned Versus New Pacemakers

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

Will Semaglutide Change Cardiac Surgery? It Already Has

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content